| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 1.70 | 0.00 (0.00%) | 1.08 - 4.95 | 1.0 (Below Avg) |
Market data as of 4:00PM 05/21/13. Quotes are delayed by at least 15 min.
| Open | -- |
|---|---|
| Previous Close | 1.70 |
| Day's Range | -- - -- |
| Market Cap | 90.3M |
| Avg Volume (10 Day) | 974.3K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -0.75 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Fail |
| Borrows within reasonable limits? | Neutral |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
BioCryst to Present at Two Upcoming Investor Conferences
Business Wire - Thursday 05/09/2013 10:00 AM ET
BioCryst Provides Corporate Update and Reports First Quarter 2013 Financial Results
Business Wire - Tuesday 05/07/2013 6:06 AM ET
BioCryst to Announce First Quarter 2013 Financial Results May 7
Business Wire - Tuesday 04/23/2013 6:30 AM ET
| BCRX | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -33.31% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | -- | |
| LT Debt/Equity | -- | |
| Earnings Yield | -- | |
| Price/Sales | 5.13 |
| Company | Last | Change |
|---|---|---|
| Codexis Inc | 2.40 | 0.00% |
| Discovery Laboratories Inc | 1.65 | 0.00% |
| Imprimis Pharmaceuticals Inc | 9.34 | 0.00% |
| Nupathe Inc | 3.15 | 0.00% |
| Prana Biotechnology Ltd | 2.42 | 0.00% |
Data is delayed by at least 15 min.